• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Veritiv Announces Second Quarter 2023 Financial Results

    8/8/23 8:00:00 AM ET
    $VRTV
    Paper
    Consumer Staples
    Get the next $VRTV alert in real time by email

    Second Quarter Highlights

    • Net Income of $70.7 million, a decrease of 22.4% from prior year
    • Diluted EPS of $5.15, a decrease of 15.8% from prior year
    • Record second quarter Adjusted EBITDA margin1 of 7.7%
    • 14 consecutive quarters of year-over-year Adjusted EBITDA margin expansion

    ATLANTA, Aug. 8, 2023 /PRNewswire/ -- Veritiv Corporation (NYSE:VRTV), a leading full-service provider of business-to-business products, services and solutions, today announced financial results for the second quarter ended June 30, 2023.

    "The second quarter highlighted the value of our diversified and complementary portfolio of products and industry verticals. Despite challenging macroeconomic conditions, Adjusted EBITDA for both Packaging and Facility Solutions improved sequentially and on a year-over-year basis, achieving record Adjusted EBITDA margins for these segments," said Sal Abbate, Chief Executive Officer. "This strong performance partially offset continued intense industry-wide destocking and slowing demand headwinds in Print Solutions, resulting in record second quarter consolidated Adjusted EBITDA margin."

    Abbate concluded, "I am excited to have reached an agreement with an affiliate of Clayton, Dubilier & Rice, LLC (CD&R) to acquire Veritiv, which we believe delivers substantial value to our shareholders. This is a testament to our team's hard work and dedication over the past several years as the successful execution of our commercial and operational excellence strategies fundamentally improved our business. The transaction will further enhance our resources and offer greater financial and operational flexibility as we deliver innovative and sustainable solutions to our customers."

    For the three months ended June 30, 2023, compared to the three months ended June 30, 2022:

    • Net sales were $1.5 billion, a decrease of 20.0% from the prior year; organic sales decreased 15.4%.
    • Net income was $70.7 million, compared to $91.1 million in the prior year. Net restructuring charges were none, compared to $1.4 million in the prior year.
    • Basic and diluted earnings per share were $5.22 and $5.15, respectively, compared to $6.24 and $6.12, respectively, in the prior year.
    • Adjusted EBITDA was $112.2 million, a decrease of 17.7% from the prior year.
    • Adjusted EBITDA margin was 7.7%, an increase of 20 basis points from the prior year.

    For the six months ended June 30, 2023, compared to the six months ended June 30, 2022:

    • Net sales were $3.0 billion, a decrease of 19.3% from the prior year; organic sales decreased 11.7%.
    • Net income was $139.4 million, compared to $169.6 million in the prior year. Net restructuring charges were none, compared to $4.1 million in the prior year.
    • Basic and diluted earnings per share were $10.30 and $10.15, respectively, compared to $11.55 and $11.23, respectively, in the prior year.
    • Adjusted EBITDA was $216.0 million, a decrease of 15.6% from the prior year.
    • Adjusted EBITDA margin was 7.3%, an increase of 30 basis points from the prior year.

    For the three months ended June 30, 2023, net cash provided by operating activities was $94.4 million and free cash flow was $91.3 million.  For the six months ended June 30, 2023, net cash provided by operating activities was $165.3 million and free cash flow was $159.3 million.

    "We are pleased with strong free cash flow of nearly $160 million generated during the first half of 2023." said Eric Guerin, Chief Financial Officer.

    In light of the previously announced transaction with CD&R, Veritiv will not provide guidance or host a conference call or webcast to review the second quarter 2023 financial results.

     1Adjusted EBITDA margin, a non-GAAP metric, is defined as Adjusted EBITDA as a percentage of net sales.

    Important information regarding measures not presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") and related reconciliations of non-GAAP financial measures to the most comparable U.S. GAAP measures can be found in the schedules to this press release, which should be thoroughly reviewed.

    About Veritiv

    Veritiv Corporation (NYSE:VRTV), headquartered in Atlanta, is a leading full-service provider of packaging, JanSan and hygiene products, services and solutions. Additionally, Veritiv provides print and publishing products.  Serving customers in a wide range of industries both in North America and globally, Veritiv has distribution centers throughout the U.S. and Mexico, and team members around the world helping shape the success of its customers. For more information about Veritiv and its business segments visit www.veritiv.com.

    Safe Harbor Provision

    This release contains certain forward-looking statements that reflect Veritiv's current views with respect to certain current and future events. Specific forward-looking statements include, among others, statements regarding the consummation of the proposed transaction. These forward-looking statements are and will be, subject to many risks, uncertainties and factors which may cause future events to be materially different from these forward-looking statements or anything implied therein. These risks and uncertainties include, but are not limited to: the timing, receipt and terms and conditions of any required governmental or regulatory approvals of the proposed transaction that could reduce the anticipated benefits of or cause the parties to abandon the proposed transaction; risks related to the satisfaction of the conditions to closing the proposed transaction (including the failure to obtain necessary regulatory approvals or the necessary approvals of the Veritiv's stockholders) in the anticipated timeframe or at all; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Veritiv's common stock; disruption from the proposed transaction making it more difficult to maintain business and operational relationships, including retaining and hiring key personnel; the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement entered into in connection with the proposed transaction; risks related to disruption of management's attention from Veritiv's ongoing business operations due to the proposed transaction; significant transaction costs; the risk of litigation and/or regulatory actions related to the proposed transaction; global economic conditions; adverse industry and market conditions; the ability to retain management and other personnel; and other economic, business, or competitive factors. Any forward-looking statements in this release are based upon information available to Veritiv on the date of this release. Veritiv does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any statements expressed or implied therein will not be realized. Additional information on risk factors that could affect Veritiv may be found in Veritiv's filings with the Securities and Exchange Commission (the "SEC").

    Additional Information and Where to Find it

    This filing may be deemed solicitation material in respect of the proposed merger of an affiliate of Clayton, Dubilier & Rice, LLC with and into Veritiv. In connection with the proposed merger transaction, Veritiv will file with the SEC and furnish to Veritiv's stockholders a proxy statement and other relevant documents. This filing does not constitute a solicitation of any vote or approval. Stockholders are urged to read the proxy statement when it becomes available and any other documents to be filed with the SEC in connection with the proposed merger or incorporated by reference in the proxy statement because they will contain important information about the proposed merger.

    Investors will be able to obtain free of charge the proxy statement and other documents filed with the SEC at the SEC's website at https://www.sec.gov. In addition, the proxy statement and Veritiv's annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 are available free of charge through Veritiv's website at https://ir.veritiv.com/ as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC.

    The directors, executive officers and certain other members of management and employees of Veritiv may be deemed "participants" in the solicitation of proxies from stockholders of Veritiv in favor of the proposed merger. Information regarding the persons who may, under the rules of the SEC, be considered participants in the solicitation of the stockholders of Veritiv in connection with the proposed merger will be set forth in the proxy statement and the other relevant documents to be filed with the SEC. You can find information about the Company's executive officers and directors in its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and in its definitive proxy statement for the 2023 annual meeting of stockholders as filed with the SEC on Schedule 14A on March 17, 2023.

    Financial Statements

     

    VERITIV CORPORATION

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (in millions, except per share data, unaudited)























    Three Months Ended

    June 30,



    Six Months Ended

    June 30,





    2023



    2022



    2023



    2022

    Net sales



    $     1,457.3



    $     1,820.7



    $     2,967.5



    $     3,678.8

    Cost of products sold (exclusive of depreciation and amortization

    shown separately below)



    1,096.6



    1,410.9



    2,240.7



    2,866.3

    Distribution expenses



    88.7



    98.2



    178.4



    210.4

    Selling and administrative expenses



    163.5



    190.7



    334.9



    378.6

    Gain on sale of businesses



    —



    (10.0)



    —



    (10.0)

    Depreciation and amortization



    9.6



    11.1



    19.7



    23.8

    Restructuring charges, net



    —



    1.4



    —



    4.1

    Operating income



    98.9



    118.4



    193.8



    205.6

    Interest expense, net



    4.3



    4.0



    9.0



    7.5

    Other (income) expense, net



    (1.9)



    (6.6)



    (0.9)



    (7.2)

    Income before income taxes



    96.5



    121.0



    185.7



    205.3

    Income tax expense



    25.8



    29.9



    46.3



    35.7

    Net income



    $           70.7



    $           91.1



    $         139.4



    $         169.6



















    Earnings per share:

















    Basic



    $           5.22



    $           6.24



    $         10.30



    $         11.55

    Diluted



    $           5.15



    $           6.12



    $         10.15



    $         11.23



















    Weighted-average shares outstanding:

















    Basic



    13.55



    14.61



    13.54



    14.69

    Diluted



    13.72



    14.88



    13.73



    15.10

     

    VERITIV CORPORATION

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (dollars in millions, except par value, unaudited)















    June 30, 2023



    December 31, 2022

    Assets









    Current assets:









    Cash and cash equivalents



    $                           43.9



    $                           40.6

    Accounts receivable, less allowances of $22.9 and $26.7, respectively



    750.5



    889.6

    Inventories



    487.0



    423.9

    Other current assets



    95.0



    103.7

    Total current assets



    1,376.4



    1,457.8

    Property and equipment (net of accumulated depreciation and amortization

    of $326.6 and $325.5, respectively)



    124.2



    127.5

    Goodwill



    96.3



    96.3

    Other intangibles, net



    33.4



    35.6

    Deferred income tax assets



    25.5



    29.0

    Other non-current assets



    366.5



    343.4

    Total assets



    $                      2,022.3



    $                     2,089.6

    Liabilities and shareholders' equity









    Current liabilities:









    Accounts payable



    $                         418.1



    $                        452.9

    Accrued payroll and benefits



    46.8



    106.2

    Other accrued liabilities



    147.2



    154.1

    Current portion of debt



    14.2



    13.4

    Total current liabilities



    626.3



    726.6

    Long-term debt, net of current portion



    171.6



    264.8

    Defined benefit pension obligations



    0.8



    0.4

    Other non-current liabilities



    340.3



    341.7

    Total liabilities



    1,139.0



    1,333.5

    Commitments and contingencies









    Shareholders' equity:









    Preferred stock, $0.01 par value, 10.0 million shares authorized, none issued



    —



    —

    Common stock, $0.01 par value, 100.0 million shares authorized; shares

    issued - 17.6 million and 17.5 million, respectively; shares outstanding - 13.6

    million and 13.5 million, respectively



    0.2



    0.2

    Additional paid-in capital



    614.9



    613.1

    Accumulated earnings



    595.0



    472.6

    Accumulated other comprehensive loss



    (9.7)



    (12.7)

    Treasury stock at cost - 4.0 million and 4.0 million shares, respectively



    (317.1)



    (317.1)

    Total shareholders' equity



    883.3



    756.1

    Total liabilities and shareholders' equity



    $                      2,022.3



    $                     2,089.6

     

    VERITIV CORPORATION

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in millions, unaudited)















    Six Months Ended June 30,





    2023



    2022

    Operating activities









    Net income



    $                     139.4



    $                     169.6

    Depreciation and amortization



    19.7



    23.8

    Amortization and write-off of deferred financing fees



    0.8



    0.8

    Net (gains) losses on disposition of assets and sale of businesses



    0.1



    (15.3)

    Provision for expected credit losses



    (1.8)



    (0.1)

    Deferred income tax provision (benefit)



    4.1



    (11.6)

    Stock-based compensation



    5.4



    5.9

    Other non-cash items, net



    (1.7)



    (7.0)

    Changes in operating assets and liabilities









    Accounts receivable



    142.0



    (51.4)

    Inventories



    (60.8)



    (25.4)

    Other current assets



    10.2



    (1.5)

    Accounts payable



    (0.7)



    23.4

    Accrued payroll and benefits



    (66.7)



    (31.8)

    Other accrued liabilities



    0.0



    (13.9)

    Other



    (24.7)



    (3.2)

    Net cash provided by (used for) operating activities



    165.3



    62.3

    Investing activities









    Property and equipment additions



    (6.0)



    (11.6)

    Proceeds from asset sales and sale of businesses, net of cash transferred



    0.3



    139.4

    Proceeds from insurance related to property and equipment



    0.1



    3.5

    Net cash provided by (used for) investing activities



    (5.6)



    131.3

    Financing activities









    Change in book overdrafts



    (36.4)



    12.9

    Borrowings of long-term debt



    2,744.0



    3,111.5

    Repayments of long-term debt



    (2,835.8)



    (3,190.9)

    Payments under right-of-use finance leases



    (4.9)



    (6.3)

    Payments under vendor-based financing arrangements



    (3.4)



    (3.2)

    Purchase of treasury stock



    —



    (104.8)

    Impact of tax withholding on share-based compensation



    (3.6)



    (29.7)

    Dividends paid to shareholders



    (17.0)



    —

    Other



    0.3



    0.3

    Net cash provided by (used for) financing activities



    (156.8)



    (210.2)

    Effect of exchange rate changes on cash



    0.4



    (0.6)

    Net change in cash and cash equivalents



    3.3



    (17.2)

    Cash and cash equivalents at beginning of period



    40.6



    49.3

    Cash and cash equivalents at end of period



    $                       43.9



    $                       32.1

    Supplemental cash flow information









    Cash paid for income taxes, net of refunds



    $                       50.7



    $                       57.8

    Cash paid for interest



    8.0



    6.4

    Non-cash investing and financing activities









    Non-cash additions to property and equipment for right-of-use finance

    leases and vendor-based financing arrangements



    $                         7.4



    $                       18.1

    Non-cash additions to other non-current assets for right-of-use operating

    leases



    45.4



    37.3

    Non-GAAP Measures 

    We supplement our financial information prepared in accordance with U.S. GAAP with certain non-GAAP measures including organic sales (net sales on an average daily sales basis, excluding revenue from sold businesses and revenue from acquired businesses for a period of 12 months after we complete the acquisition), Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, restructuring charges, net, integration and acquisition expenses and other similar charges including any severance costs, costs associated with warehouse and office openings or closings, consolidation, and relocation and other business optimization expenses, stock-based compensation expense, changes in the LIFO reserve, non-restructuring asset impairment charges, non-restructuring severance charges, non-restructuring pension charges (benefits), fair value adjustments related to contingent liabilities assumed in mergers and acquisitions and certain other adjustments), free cash flow and other non-GAAP measures such as the Net Leverage Ratio (calculated as net debt divided by trailing twelve months of Adjusted EBITDA) and Return on Invested Capital "ROIC" (calculated as Net Operating Profit After Tax divided by the sum of net working capital and property and equipment. Net Operating Profit After Tax is defined as Adjusted EBITDA less depreciation and amortization times 1 minus the standard tax rate1). We believe investors commonly use Adjusted EBITDA, free cash flow and these other non-GAAP measures as key financial metrics for valuing companies; we also present organic sales to help investors better compare period-over-period results. In addition, the credit agreement governing our Asset-Based Lending Facility (the "ABL Facility") permits us to exclude the foregoing and other charges in calculating "Consolidated EBITDA", as defined in the ABL Facility. Consolidated EBITDA and ROIC are also used as a basis for certain compensation programs sponsored by the Company.

    Organic sales, Adjusted EBITDA, free cash flow and these other non-GAAP measures are not alternative measures of financial performance or liquidity under U.S. GAAP. Non-GAAP measures do not have definitions under U.S. GAAP and may be defined differently by, and not be comparable to, similarly titled measures used by other companies. As a result, we consider and evaluate non-GAAP measures in connection with a review of the most directly comparable measure calculated in accordance with U.S. GAAP. We caution investors not to place undue reliance on such non-GAAP measures and to consider them with the most directly comparable U.S. GAAP measures. Organic sales, Adjusted EBITDA, free cash flow and these other non-GAAP measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analyzing our results as reported under U.S. GAAP. Please see the following tables for reconciliations of non-GAAP measures to the most comparable U.S. GAAP measures.

    1 The Company uses a standard tax rate of 26%.

     

    Table I

    VERITIV CORPORATION

    RECONCILIATION OF NON-GAAP MEASURES

    NET INCOME TO ADJUSTED EBITDA; ADJUSTED EBITDA MARGIN

    (in millions, unaudited)















    Three Months Ended

    June 30,



    Six Months Ended

    June 30,





    2023



    2022



    2023



    2022

    Net income



    $         70.7



    $         91.1



    $      139.4



    $       169.6

    Interest expense, net



    4.3



    4.0



    9.0



    7.5

    Income tax expense



    25.8



    29.9



    46.3



    35.7

    Depreciation and amortization



    9.6



    11.1



    19.7



    23.8

    EBITDA



    110.4



    136.1



    214.4



    236.6

    Restructuring charges, net



    —



    1.4



    —



    4.1

    Gain on sale of businesses



    —



    (10.0)



    —



    (10.0)

    Facility closure charges, including (gain) loss from asset

    disposition



    0.1



    (0.3)



    0.0



    (0.9)

    Stock-based compensation



    3.6



    3.1



    5.4



    5.9

    LIFO reserve (decrease) increase



    (3.5)



    11.8



    (6.0)



    22.8

    Non-restructuring severance charges



    (0.2)



    (0.2)



    0.1



    1.5

    Non-restructuring pension charges (benefits)



    (1.0)



    (7.0)



    (0.8)



    (7.0)

    Other



    2.8



    1.4



    2.9



    2.8

    Adjusted EBITDA



    $      112.2



    $      136.3



    $      216.0



    $       255.8



















    Net sales



    $   1,457.3



    $   1,820.7



    $   2,967.5



    $   3,678.8

    Adjusted EBITDA as a % of net sales



    7.7 %



    7.5 %



    7.3 %



    7.0 %

     

    Table II

    VERITIV CORPORATION

    RECONCILIATION OF NON-GAAP MEASURES

    FREE CASH FLOW

    (in millions, unaudited)

























    Three Months Ended

    June 30, 2023



    Six Months Ended

    June 30, 2023

    Net cash provided by (used for) operating activities



    $                                 94.4



    $                              165.3

    Less: Capital expenditures



    (3.1)



    (6.0)

    Free cash flow



    $                                 91.3



    $                              159.3

     

    Table III

    VERITIV CORPORATION

    RECONCILIATION OF NON-GAAP MEASURES

    REPORTED NET SALES TO ORGANIC SALES

    (in millions, unaudited)























    Three Months Ended

    June 30,



    Six Months Ended

    June 30,





    2023



    2022



    2023



    2022

    Reported net sales



    $      1,457.3



    $      1,820.7



    $      2,967.5



    $      3,678.8

    Impact of change in selling days (1)



    —



    —



    —



    —

    Net sales (on an average daily sales basis)



    1,457.3



    1,820.7



    2,967.5



    3,678.8

    Business divestitures (2)



    —



    (98.4)



    —



    (319.0)

    Organic sales



    $      1,457.3



    $      1,722.3



    $      2,967.5



    $      3,359.8



















    Business Days



    64



    64



    127



    127

    (1) Adjustment for differences in the number of selling days, if any.

    (2) Represents the net sales of each of the following divested businesses prior to its respective divestiture: Veritiv Canada, Inc. (May 2, 2022) and the

            logistics solutions business (September 1, 2022).

     

    Veritiv Corporation Logo (PRNewsFoto/Veritiv Corporation) (PRNewsfoto/Veritiv Corporation)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/veritiv-announces-second-quarter-2023-financial-results-301895129.html

    SOURCE Veritiv Corporation

    Get the next $VRTV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VRTV

    DatePrice TargetRatingAnalyst
    8/10/2021$72.00 → $86.00Buy
    B of A Securities
    More analyst ratings

    $VRTV
    Financials

    Live finance-specific insights

    See more
    • Veritiv Announces Second Quarter 2023 Financial Results

      Second Quarter Highlights Net Income of $70.7 million, a decrease of 22.4% from prior yearDiluted EPS of $5.15, a decrease of 15.8% from prior yearRecord second quarter Adjusted EBITDA margin1 of 7.7%14 consecutive quarters of year-over-year Adjusted EBITDA margin expansionATLANTA, Aug. 8, 2023 /PRNewswire/ -- Veritiv Corporation (NYSE:VRTV), a leading full-service provider of business-to-business products, services and solutions, today announced financial results for the second quarter ended June 30, 2023. "The second quarter highlighted the value of our diversified and complementary portfolio of products and industry verticals. Despite challenging macroeconomic conditions, Adjusted EBITDA

      8/8/23 8:00:00 AM ET
      $VRTV
      Paper
      Consumer Staples
    • Veritiv Corporation to be Acquired by CD&R

      Shareholders to Receive $170 Per Share in CashTransaction Expected to Close in the Fourth Quarter of 2023Veritiv Board of Directors Approves Quarterly Dividend of $0.63 Per Share ATLANTA, Aug. 7, 2023 /PRNewswire/ -- Veritiv Corporation (NYSE:VRTV), a leading distributor of packaging, facility solutions and print products, announced today that it has entered into a definitive agreement to be acquired by an affiliate of Clayton, Dubilier & Rice, LLC (CD&R). Under the terms of the agreement, each share of Veritiv common stock issued and outstanding immediately prior to the closing of the transaction will be entitled to receive $170 per share in cash, representing a nearly 31% premium over Veri

      8/7/23 8:00:00 AM ET
      $VRTV
      Paper
      Consumer Staples
    • Veritiv to Release Second Quarter 2023 Financial Results on August 8

      ATLANTA, July 21, 2023 /PRNewswire/ -- Veritiv Corporation (NYSE:VRTV) will host a live conference call and webcast to discuss its second quarter 2023 financial results on Tuesday, August 8, at 9 a.m. ET. To participate, callers within the U.S. and Canada can dial (888) 330-2469 using conference ID number 3047006. International callers can use the following link for international access numbers. https://events.evolveirportal.com/custom/access/2324  Interested parties can also listen online at ir.veritivcorp.com. A replay of the call and webcast will be available online for a limited period at ir.veritivcorp.com shortly after the live webcast is completed. Prior to the August 8 financial resu

      7/21/23 8:00:00 AM ET
      $VRTV
      Paper
      Consumer Staples

    $VRTV
    SEC Filings

    See more
    • SEC Form 15-12G filed by Veritiv Corporation

      15-12G - Veritiv Corp (0001599489) (Filer)

      12/11/23 4:15:58 PM ET
      $VRTV
      Paper
      Consumer Staples
    • SEC Form EFFECT filed by Veritiv Corporation

      EFFECT - Veritiv Corp (0001599489) (Filer)

      12/5/23 12:15:05 AM ET
      $VRTV
      Paper
      Consumer Staples
    • SEC Form POS AM filed by Veritiv Corporation

      POS AM - Veritiv Corp (0001599489) (Filer)

      11/30/23 10:21:44 AM ET
      $VRTV
      Paper
      Consumer Staples

    $VRTV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $VRTV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Baupost Group Llc/Ma disposed of $565,135,080 worth of shares (3,324,324 units at $170.00) (SEC Form 4)

      4 - Veritiv Corp (0001599489) (Issuer)

      12/6/23 4:50:12 PM ET
      $VRTV
      Paper
      Consumer Staples
    • Ward Charles returned $2,550,000 worth of shares to the company (15,000 units at $170.00), closing all direct ownership in the company (SEC Form 4)

      4 - Veritiv Corp (0001599489) (Issuer)

      11/30/23 12:08:27 PM ET
      $VRTV
      Paper
      Consumer Staples
    • SEC Form 4 filed by Muldowney Michael P

      4 - Veritiv Corp (0001599489) (Issuer)

      11/30/23 12:08:13 PM ET
      $VRTV
      Paper
      Consumer Staples
    • B of A Securities reiterated coverage on Veritiv with a new price target

      B of A Securities reiterated coverage of Veritiv with a rating of Buy and set a new price target of $86.00 from $72.00 previously

      8/10/21 10:52:15 AM ET
      $VRTV
      Paper
      Consumer Staples

    $VRTV
    Leadership Updates

    Live Leadership Updates

    See more
    • ITT Announces Appointment of Mary Laschinger to Board of Directors

      May 21, 2025-- ITT Inc. (NYSE: ITT) today announced the election of Mary Laschinger to its Board of Directors, effective today. Ms. Laschinger served as Chief Executive Officer and Chair of the Board of Directors of Veritiv Corporation (NYSE:VRTV), a leading business-to-business distribution solutions company, from July 2014 until her retirement in September 2020. Prior to leading Veritiv, Ms. Laschinger held multiple senior management roles over more than 20 years at International Paper Company. "We are honored that Mary has joined the ITT Board of Directors. She has significant global experience with industrial companies that operate in markets similar to ITT, as well as a track record

      5/21/25 4:15:00 PM ET
      $ITT
      $VRTV
      Fluid Controls
      Industrials
      Paper
      Consumer Staples
    • Carlyle Group and WP Carey Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

      NEW YORK, Nov. 27, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, November 30: Carlyle Group Inc. (NASD: CG) will replace ICU Medical Inc. (NASD: ICUI) in the S&P MidCap 400. ICU Medical will replace PacWest Bancorp (NASD: PACW) in the S&P SmallCap 600. Banc of California Inc. (NYSE:BANC) is acquiring PacWest Bancorp in a deal expected to be completed soon, pending final closing conditions. Post-merger, Banc of California will remain in the S&P SmallCap 600. ICU Medical is more representative of the small-cap market space.WP Carey Inc. (NYSE: WPC) will replace Worthingt

      11/27/23 6:28:00 PM ET
      $AVTA
      $BANC
      $CG
      $CWEN
      Finance: Consumer Services
      Finance
      Major Banks
      Investment Managers
    • Sleep Number Appoints Two New Independent Directors, Stephen Macadam and Hilary Schneider

      Announces Cooperation Agreement with Shareholder Stadium Capital Board to Form a Capital Allocation Committee, Comprised of New and Tenured Directors, to Provide Analysis and Recommendations to Board Sleep Number Corporation (NASDAQ:SNBR) today announced that it has appointed Stephen E. Macadam and Hilary A. Schneider to its Board of Directors (the "Board"), effective immediately, expanding the Board to twelve members. In conjunction with the appointments, Sleep Number entered into a cooperation agreement (the "Cooperation Agreement") with Stadium Capital Management, LLC (collectively with its affiliates, "Stadium Capital"), one of the company's shareholders. Steve Macadam is the Chai

      11/7/23 4:01:00 PM ET
      $ATMU
      $BXC
      $DOCN
      $GETY
      Auto Parts:O.E.M.
      Consumer Discretionary
      Wholesale Distributors
      Computer Software: Programming Data Processing

    $VRTV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ITT Announces Appointment of Mary Laschinger to Board of Directors

      May 21, 2025-- ITT Inc. (NYSE: ITT) today announced the election of Mary Laschinger to its Board of Directors, effective today. Ms. Laschinger served as Chief Executive Officer and Chair of the Board of Directors of Veritiv Corporation (NYSE:VRTV), a leading business-to-business distribution solutions company, from July 2014 until her retirement in September 2020. Prior to leading Veritiv, Ms. Laschinger held multiple senior management roles over more than 20 years at International Paper Company. "We are honored that Mary has joined the ITT Board of Directors. She has significant global experience with industrial companies that operate in markets similar to ITT, as well as a track record

      5/21/25 4:15:00 PM ET
      $ITT
      $VRTV
      Fluid Controls
      Industrials
      Paper
      Consumer Staples
    • CD&R Completes Acquisition of Veritiv Corporation

      Veritiv Becomes Privately Held Company ATLANTA, Nov. 30, 2023 /PRNewswire/ -- Veritiv Corporation, a leading distributor of packaging, facility solutions, and print products, today announced that an affiliate of Clayton, Dubilier & Rice, LLC (CD&R) completed its acquisition of the company. On August 7, 2023, CD&R and Veritiv announced they had entered into a definitive agreement under which each share of Veritiv common stock issued and outstanding immediately prior to the closing of the transaction would be acquired for $170.00 per share in cash, valuing Veritiv at approximately $2.6 billion.  "The completion of this transaction represents an important milestone in our company's journey," sa

      11/30/23 9:28:00 AM ET
      $VRTV
      Paper
      Consumer Staples
    • Carlyle Group and WP Carey Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

      NEW YORK, Nov. 27, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, November 30: Carlyle Group Inc. (NASD: CG) will replace ICU Medical Inc. (NASD: ICUI) in the S&P MidCap 400. ICU Medical will replace PacWest Bancorp (NASD: PACW) in the S&P SmallCap 600. Banc of California Inc. (NYSE:BANC) is acquiring PacWest Bancorp in a deal expected to be completed soon, pending final closing conditions. Post-merger, Banc of California will remain in the S&P SmallCap 600. ICU Medical is more representative of the small-cap market space.WP Carey Inc. (NYSE: WPC) will replace Worthingt

      11/27/23 6:28:00 PM ET
      $AVTA
      $BANC
      $CG
      $CWEN
      Finance: Consumer Services
      Finance
      Major Banks
      Investment Managers

    $VRTV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Veritiv Corporation (Amendment)

      SC 13G/A - Veritiv Corp (0001599489) (Subject)

      2/9/24 9:59:19 AM ET
      $VRTV
      Paper
      Consumer Staples
    • SEC Form SC 13D/A filed by Veritiv Corporation (Amendment)

      SC 13D/A - Veritiv Corp (0001599489) (Subject)

      12/4/23 4:15:11 PM ET
      $VRTV
      Paper
      Consumer Staples
    • SEC Form SC 13D filed by Veritiv Corporation

      SC 13D - Veritiv Corp (0001599489) (Subject)

      8/11/23 2:28:44 PM ET
      $VRTV
      Paper
      Consumer Staples